Does calprotectin more accurately discriminate the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants?
Calprotectin serum levels seem to be an accurate biomarker for assessing disease activity in RA patients receiving TCZ.
Low-magnitude, high-frequency vibration with rest days altered bone microarchitecture and macro-biomechanical properties, and VL7R was more efficacious in improving bone loss caused by mechanical disuse, which provided theoretical basis and explored the mechanisms of vibration for improving bone quality in clinics.